Tylenol PM
- Product NDC
- 73097-013
- 11-digit product format
- 730970013
- Labeler code
- 73097
- Product ID
- 73097-013_518f65e6-62bf-d778-e063-6394a90a67de
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Savings Distributors LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2019-07-22
- Substance
- ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE
- Active strength
- 500; 25 mg/1; mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 73097-013-40 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 73097-013-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 73097-013-50 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 73097-013-40 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 73097-013-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 73097-013-50 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 73097-013-40 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 73097-013-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 73097-013-50 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 73097-013-40 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 73097-013-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 73097-013-50 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 73097-013-40 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 73097-013-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 73097-013-50 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 73097-013-40 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 73097-013-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 73097-013-50 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 73097-013-40 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 73097-013-02 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 73097-013-50 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 73097-013-40 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 73097-013-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 73097-013-50 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 73097-013-40 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 73097-013-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 73097-013-50 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 73097-013-40 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 73097-013-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 73097-013-50 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 73097-013-40 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 73097-013-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 73097-013-50 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 73097-013-40 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 73097-013-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 73097-013-50 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 73097-013-40 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 73097-013-02 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 73097-013-50 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 73097-013-40 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 73097-013-02 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 73097-013-50 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 73097-013-40 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 73097-013-02 | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 73097-013-50 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tylenol PM
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
| DIPHENHYDRAMINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| TC2D6JAD40 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 73097-013-02 | 2023-01-30 | C162847 | 48780-1 | f386c649-cd9d-0266-e053-dadaa90a7c1a | Tylenol PM |
| 73097-013-40 | 2023-01-30 | C162847 | 48780-1 | f386c649-cd9d-0266-e053-dadaa90a7c1a | Tylenol PM |
| 73097-013-50 | 2023-01-30 | C162847 | 48780-1 | f386c649-cd9d-0266-e053-dadaa90a7c1a | Tylenol PM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73097-013-02 | Tylenol PM | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 3 | |
| 73097-013-02 | Tylenol PM | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 73097-013-40 | Tylenol PM | 20 in 1 CARTON | TABLET, FILM COATED | 20 | 3 | |
| 73097-013-40 | Tylenol PM | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 | |
| 73097-013-50 | Tylenol PM | 25 in 1 CARTON | TABLET, FILM COATED | 25 | 3 | |
| 73097-013-50 | Tylenol PM | 2 in 1 POUCH | TABLET, FILM COATED | 2 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walmart Inc. | 1557bd9b-3e7c-4769-e063-6394a90a9d91 | 2025-11-04 | Warnings | M013 |
| Adult Low Dose Aspirin | ASPIRIN | Rising Pharma Holdings, Inc. | c3c4854e-726e-4926-b044-a5094943c306 | 2025-11-04 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 3e50b3f6-1e1a-41b9-e063-6394a90abe36 | 2025-11-03 | Warnings | M013 |
| Good Sense Pain Relief | ACETAMINOPHEN | L. Perrigo Company | 447de441-7d28-4415-81c5-4fc05622dd05 | 2025-11-03 | Warnings | M013 |
| Children Acetaminophen Oral Solution | ACETAMINOPHEN | VERITYRX. LLC | 42a17f54-7851-84fb-e063-6394a90a9ec1 | 2025-11-02 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | VERITYRX, LLC | 42a1a128-a2dd-bbc9-e063-6294a90a4fe1 | 2025-11-02 | Warnings | M013 |
| Physicians Care Aspirin | ASPIRIN | Acme United Corporation | aa67ea3a-2741-7ee0-e053-2a95a90a6485 | 2025-10-31 | Warnings | M013 |
| PhysiciansCare Non Aspirin Extra Strength | ACETAMINOPHEN | Acme United Corporation | c7006775-bd5b-412f-963d-ce5a158216c5 | 2025-10-31 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | Walgreens | f7aa624b-b00c-4fd3-9965-8e4d2b3eb4ba | 2025-10-31 | Warnings | M013 |
| Extra Strength Acetaminophen | ACETAMINOPHEN | NuCare Pharmaceuticals, Inc. | 41affa1a-5aac-7fc0-e063-6394a90a5557 | 2025-10-30 | Warnings | M013 |
| MAPAP Extra Strength | ACETAMINOPHEN | Major Pharmaceuticals | 34a95450-3f04-4de4-9113-73e7bd5724a0 | 2025-10-29 | Warnings | M013 |
| GOODNOW PAIN RELIEF | ACETAMINOPHEN | Gobrands, Inc | 4d4a78a5-5a88-4f24-b685-c7c6bb5e989e | 2025-10-29 | Warnings | M013 |
| Sanaflu Xtra | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | GRANDALL DISTRIBUTING, LLC | 4af8a566-5251-4d46-8692-87a3a0748334 | 2025-10-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rising Pharma Holdings, Inc. | f8237772-7656-49fb-b1de-f8fcb5fa55ee | 2025-10-28 | Warnings | M013 |
| DG Health Pain Relief | ACETAMINOPHEN | Dolgencorp Inc | 42f0c87c-7020-4af7-9f6b-3a774137e564 | 2025-10-24 | Warnings | M013 |
| GOODYS Hangover | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 0b0067e0-58b0-4581-aa4b-e398c32c559a | 2025-10-23 | Warnings | M013 |
| GOODYS Extra Strength Headache Mixed Fruit Blast | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 6cb758bf-5a50-46bb-96e7-65b810b12de0 | 2025-10-23 | Warnings | M013 |
| Nyt Time Sleep Caps | DIPHENHYDRAMINE HYDROCHLORIDE | DISCOUNT DRUG MART | e3f4d063-921d-4503-89a6-26cc9c46b4c9 | 2025-10-23 | Warnings | M013 |
| Anacin | ASPRIN AND CAFFEINE | Insight Pharmaceuticals LLC | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 2025-10-23 | Warnings | M013 |
| Goodys Back and Body Pain | ACETAMINOPHEN AND ASPRIN | Medtech Products Inc. | 055d0288-61d4-48bc-b91f-6ecc1969beb8 | 2025-10-23 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1092189 | acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG Oral Tablet | PSN | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092378 | Tylenol PM 500 MG / 25 MG Oral Tablet | PSN | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092378 | acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet [Tylenol PM] | SBD | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092189 | acetaminophen 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SCD | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092189 | APAP 500 MG / diphenhydramine hydrochloride 25 MG Oral Tablet | SY | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092378 | APAP 500 MG / Diphenhydramine Hydrochloride 25 MG Oral Tablet [Tylenol PM] | SY | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092378 | Tylenol PM (APAP 500 MG / diphenhydramine hydrochloride 25 MG) Oral Tablet | SY | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
| 1092378 | Tylenol PM Extra Strength (APAP 500 MG / diphenhydramine hydrochloride 25 MG) Oral Tablet | SY | 8ed9a9f0-d37e-5c10-e053-2a95a90a559f | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 73097-013-02 | 73097001302 | 1 POUCH in 1 CARTON (73097-013-02) / 2 TABLET, FILM COATED in 1 POUCH | 1 pouch | 2019-07-22 | 0000-00-00 | No | No | Current |
| 73097-013-40 | 73097001340 | 20 POUCH in 1 CARTON (73097-013-40) / 2 TABLET, FILM COATED in 1 POUCH | 20 pouch | 2019-07-22 | 0000-00-00 | No | No | Current |
| 73097-013-50 | 73097001350 | 25 POUCH in 1 CARTON (73097-013-50) / 2 TABLET, FILM COATED in 1 POUCH | 25 pouch | 2019-07-22 | 0000-00-00 | No | No | Current |